The results demonstrated that SHANK2 methylation level was significantly higher in luminal B Her2(+) and Triple-negative breast cancer samples, than that in normal, luminal A and luminal B Her2(-) samples, which implicated a positive correlation between SHANK2 methylation and high metastatic potential (Figure 3B–E). Here, SHANK2 is linked to breast carcinoma.